| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 700e 1st St E, Ogallala, Nebraska 69153 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (308) 284-2020 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
Children are grossly underdiagnosed for sleep disordered breathing, which includes obstructive sleep apnea (OSA), and the symptoms may be wrongly attributed to behavior issues, according to research in the Journal of the American Osteopathic Association.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
The international research team led by the University of Leeds found that the TSPAN12 gene is faulty in patients with a disease known as FEVR (Familial Exudative Vitreoretinopathy), which affects the development of the eye.
› Verified 1 days ago
| NPI Number | 1043379563 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 700 E 1st St, Ste E, Ogallala, NE 69153 |
| Phone Number | 308-284-2020 |
News Archive
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
Children are grossly underdiagnosed for sleep disordered breathing, which includes obstructive sleep apnea (OSA), and the symptoms may be wrongly attributed to behavior issues, according to research in the Journal of the American Osteopathic Association.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
The international research team led by the University of Leeds found that the TSPAN12 gene is faulty in patients with a disease known as FEVR (Familial Exudative Vitreoretinopathy), which affects the development of the eye.
› Verified 1 days ago
News Archive
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
Children are grossly underdiagnosed for sleep disordered breathing, which includes obstructive sleep apnea (OSA), and the symptoms may be wrongly attributed to behavior issues, according to research in the Journal of the American Osteopathic Association.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
The international research team led by the University of Leeds found that the TSPAN12 gene is faulty in patients with a disease known as FEVR (Familial Exudative Vitreoretinopathy), which affects the development of the eye.
› Verified 1 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 700e 1st St E, Ogallala, Nebraska 69153 Phone: (308) 284-2020 | |
Ogallala Eyecare, P.c. Type: Medicare Supplier Location: 211 N Spruce St, Ogallala, Nebraska 69153 Phone: (308) 284-4394 | |
Safeway Pharmacy #0557 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 611 N Spruce St, Ogallala, Nebraska 69153 Phone: (308) 284-3670 | |
U-save Pharmacy Ogallala Type: Long Term Care Pharmacy Location: 23 N Spruce St, Ogallala, Nebraska 69153 Phone: (308) 284-2242 | |
Walmart Pharmacy 10-7129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 201 Pony Express Lane, Ogallala, Nebraska 69153 Phone: (308) 284-0118 |